• FDA to end controversial pharmafile
    May 15, 2019
    The FDA has revealed that it plans to terminate its "alternative summary reporting" programme which has allowed the manufacturers of medical devices to keep undesirable reports of malfunctions and adverse events out of public knowledge.
  • Incyte Announces CFO to Retire at End of 2018 americanpharmaceuticalreview
    September 10, 2018
    Incyte announced that David Gryska, Executive Vice President and Chief Financial Officer, intends to retire at the end of 2018 and that Incyte has launched a search for his replacement.
PharmaSources Customer Service